Loading, please wait...
 Texas Opioid Training InitiativeTreatment Strategies for Substance Use DisordersThis course is part of the Texas Opioid Training Initiative (TXOTI), an educational initiative that provides free continuing education training to healthcare professionals about topics related to the opioid crisis. Visit TXOTI.org to view the full list of courses offered by TXOTI. The sessions in this course were recorded at the 2023 Texas Substance Use Symposium (TxSUS) and they focus on evidence-based treatment strategies for a variety of substance use disorders. Healthcare professionals are encouraged to complete all four modules to gain a full conceptual understanding of the topics discussed in this course. While the information in this activity has been specifically tailored for clinicians practicing in Texas by focusing on regional trends, laws and regulations, the core concepts are applicable to all healthcare professionals. ModulesThe following modules are included in this course. To view more information about each module, scroll down and click the light blue tabs that appear below. Once you are registered and logged into the course, you will have access to course materials in each module tab below (e.g., video, slides, post-test, and evaluation).
FormatEach module consists of a video (MP4 format) along with presentation slides (PDF format). Some modules also include links to additional references and resources as recommended by the presenter. All videos and presentation slides are accessible upon registering for the course (registration instructions listed further down the page). Learners may choose to take one or all of the modules. CE credit is awarded for each module that is completed. Completion of each module includes reviewing the course materials, completing the post-test (no minimum score), and submitting an evaluation. CE Credit is listed on your CE certificate, which is accessed by clicking "View/Print CE Credit" listed at the top of the page. The CE certificate remains available in the learner's CE profile for future access. NOTE: Pharmacy CE credit is automatically transmitted via CPE Monitor using the NABP e-profile ID entered during registration. FacultyThank you to the following faculty who developed the content for this course. Faculty biographies and disclosure statements are listed in their respective modules (see light blue tabs below).
Financial DisclosureThis training is supported by Texas Targeted Opioid Response, a public health initiative operated by the Texas Health and Human Services Commission through federal funding from the Substance Abuse and Mental Health Services Administration, grant award number - H79TI085747. Click here to view the financial disclosure statements for the planning committee. The financial disclosure statement for each individual faculty member is available by clicking their respective module below (see light blue tabs below). Continuing Education Information
The UT Health San Antonio Joe R. & Teresa Lozano Long School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Long School of Medicine designates this material for a maximum of 3.0 AMA PRA Category 1 Credit™ The University of Texas at Austin School of Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Please note: CNE credit on these courses expires June 1, 2025. Requirements for Successful Completion: To receive contact hours for this continuing education activity, the participant must sign in, view the entire activity, complete the post-test, and complete and submit the evaluation form. Once successful completion has been verified, a “Certificate of Successful Completion” will be awarded for 3.0 contact hours. Conflicts of Interest: A conflict of interest occurs when an individual has an opportunity to affect or impact educational content with which he or she may have a commercial interest or a potentially biasing relationship of a financial nature. All planners and presenters/authors/content reviewers must disclose the presence or absence of a conflict of interest relative to this activity. The activity’s Nurse Planner has determined that the following planning committee member(s) and/or presenter(s)/author(s)/content reviewer(s) have a conflict of interest. These conflicts of interest have been appropriately resolved:
The Office of Professional Development at The University of Texas at Austin Steve Hicks School of Social Work is accredited by the Council on Social Work Education, and as such receives automatic approval as a continuing education provider by the Texas Board of Social Work Examiners under Texas Administrative Code, Title 22, Part 34. § 781.511(c). The program represented by this certificate was provided in accordance with the criteria and standards of the Texas State Board of Social Worker Examiners, and has been approved for Social Workers, Licensed Professional Counselors, and Licensed Marriage and Family Therapists. Please note that 1 hour = 1 CEU. Complaints about this program may be made to TSBSWE 333 Guadalupe St, Tower 3, Room 900, Austin, TX 78701 • 512-305-7700 • 800-821-3205 • bhec.texas.gov/texas-state-board-of-social-worker-examiners/
|
Buprenorphine Induction Strategies in the Age of FentanylCarlos F. Tirado, MD, MPH, FASAM
Chief Medical Officer
CARMAhealth
|
OVERVIEW
This module assesses buprenorphine-based treatment of opioid use disorder in individuals who use fentanyl. It will examine the rationale behind three different approaches to initiate buprenorphine treatment, while discussing advantages and disadvantages for each approach.
SPEAKER
Charlos F. Tirado, M.D., earned his MD and MPH degrees at UT Health. He completed residency at UT Southwestern and fellowship at the University of Pennsylvania. He is now the chief medical officer for CARMAhealth and an associate professor of practice at The University of Texas at Austin College of Pharmacy.
SPEAKER DISCLOSURE
Dr. Tirado has the following financial relationships:
• Spark Biomedical, Medical Advisor and Co-PI for a funded project
Mitigation Statement: All relevant financial relationships with eligible companies that are reported by planners and speakers have been mitigated prior to starting their roles in this activity. (as defined by the Standards for Integrity and Independence).
LEARNING OBJECTIVES
FUNDING DISCLOSURE
This project is funded by the Texas Targeted Opioid Response, an public health initiative operated by TX Health & Human Services.
CE DETAILS
The Other MAT: Medications for Alcohol and Stimulant Use DisordersSidarth Wakhlu, MD
Professor of Psychiatry, Distinguished Teaching Professor
Clinical Director, Addiction Psychiatry Service
UT Southwestern Medical Center
|
OVERVIEW
This module discusses the current epidemiology of alchohol and stimulant use disorders. It also identifies factors that are likely responsible for underutilization of medications for substance use disorders. Lastly, the module assesses various evidence-based therapies that address alcohol and stimulant misuse.
SPEAKER
Sidarth Wakhlu, MD, is a Professor in the Department of Psychiatry at UT Southwestern Medical Center. He specializes in treating substance use disorders, including chemical dependencies and behavioral addictions such as gambling, porn, and gaming. He is Director of the Addiction Psychiatry Fellowship Program and Associate Director of the Addiction Division in the Department of Psychiatry. Dr. Wakhlu earned his medical degree at University of Delhi/Maulana Azad Medical College in India. He completed a residency in psychiatry at the University of Tennessee College of Medicine and received advanced training in addiction psychiatry through a fellowship at UT Southwestern. Certified by the American Board of Psychiatry and Neurology in addiction psychiatry, Dr. Wakhlu joined the UT Southwestern faculty in 2003. Dr. Wakhlu is a member of several professional committees, including the Southwestern Health Resources Behavioral Health Subcommittee, the Physician Health & Wellness (PHW) Committee for the Texas Medical Association, and the UT Southwestern Medical School Admission Committee. He is chair of the Student Assistance Committee at UT Southwestern. He has earned numerous awards and honors for his teaching, including induction into the Southwestern Academy of Teachers (SWAT) at UT Southwestern in 2017. Dr. Wakhlu has delivered scores of presentations, contributed to the second edition of Treating Substance Abuse, and published several academic articles.
SPEAKER DISCLOSURE
Dr. Wakhlu does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
LEARNING OBJECTIVES
FUNDING DISCLOSURE
This project is funded by the Texas Targeted Opioid Response, an public health initiative operated by TX Health & Human Services.
CE DETAILS
Treatment of Substance Use Disorders in Youth: Promoting Patient and Family-Centered Harm-Reduction ApproachesBarbara Robles-Ramamurthy, MD
Assistant Professor
UT Health San Antonio
|
OVERVIEW
This module explores the inter-relationship between mental illness, trauma and substance use disorders. It examines pharmacological interventions for opioid use disorder in youth and the challenges experienced by patients, clinicians, and community support systems when accessing or providing such treatments. Lastly, it describes evidence-based practices that can reduce harm in youth with substance use disorders, while also enhancing treatment engagement.
SPEAKER
Dr. Barbara Robles-Ramamurthy is a triple board-certified Adult, Child and Adolescent and Forensic Psychiatrist. She is an Assistant Professor of Psychiatry and Behavioral Sciences at the University of Texas Health San Antonio where she is the Director of Psychiatric Services at the Bexar County Juvenile Detention Center and the Director of the South Texas Psychiatric Practice-based Research Network. She is the founder of Teku, an online platform supporting family mental health through education and caregiver empowerment to promote justice and healing-center practices. Her scholarly work and research have focused on improving community care and advocacy for historically marginalized communities. She is a nationally recognized leader in mental health equity as it relates to child development with a focus on communities interacting with multiple systems, such as healthcare, immigration, child welfare and juvenile justice and has served on national committees in the American Psychiatric Association and the American Academy of Child and Adolescent Psychiatry. She is a visionary for improving child and family mental health through a holistic and justice-oriented approach that nourishes not only the child and family, but also their communities and the world.
SPEAKER DISCLOSURE
Dr. Robles-Ramamurthy does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
LEARNING OBJECTIVES
FUNDING DISCLOSURE
This project is funded by the Texas Targeted Opioid Response, an public health initiative operated by TX Health & Human Services.
CE DETAILS
Stigma Kills - Addressing Opioid and Substance Use Disorder by Changing Health System CultureRichard Bottner, DHA, PA-C, CPHQ, FACHE
Vice President, Clinical Excellence
Colorado Hospital Association
|
OVERVIEW
This module takes a look at how stigma in healthcare impacts the delivery of evidence-based care for people who use drugs. It describes interventions that health systems and organizations can take to address stigma, ultimately to improve clinical outcomes for patients.
SPEAKER
Richard Bottner, DHA, PA-C, CPHQ, FACHE is the Vice President of Clinical Excellence at the Colorado Hospital Association (CHA) and exceptionally passionate about effective, efficient, and interprofessional acute care in hospitals nationwide. In his current role, Dr. Bottner supports strategy and implementation related to a statewide alternative payment pilot associated with care delivery in hospitals. Dr. Bottner also focuses on statewide quality and process improvement programs surrounding several critical areas including substance use disorders, maternal health, rural and critical access hospitals, and social determinants of health.
SPEAKER DISCLOSURE
Richard Bottner does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
LEARNING OBJECTIVES
FUNDING DISCLOSURE
This project is funded by the Texas Targeted Opioid Response, an public health initiative operated by TX Health & Human Services.
CE DETAILS
